| Stage | DHI | % of rev | TMHC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.2B | 100.00% | $1.4B | 100.00% | DHI ×6.65 |
| Gross profit | $2.1B | 23.26% | $291M | 20.95% | DHI +2.3pp |
| Operating income | $1.2B | 12.52% | $142M | 10.22% | DHI +2.3pp |
| Pre-tax income | $1.2B | 13.29% | $131M | 9.42% | DHI +3.9pp |
| Net income | $919M | 9.96% | $100M | 7.24% | DHI +2.7pp |
| Stage | DHI | TMHC | Gap · A − B |
|---|---|---|---|
| Revenue | $9.2B100.00% | $1.4B100.00% | DHI ×6.65 |
| Gross profit | 23.26%$2.1B | 20.95%$291M | DHI +2.3pp |
| Operating income | 12.52%$1.2B | 10.22%$142M | DHI +2.3pp |
| Pre-tax income | 13.29%$1.2B | 9.42%$131M | DHI +3.9pp |
| Net income |
| 9.96%$919M |
| 7.24%$100M |
| DHI +2.7pp |
DHI · PCYO 10-KNov 12 '25
“Melody (DR Horton) 30 % 19 %”
TMHC · PCYO 10-KNov 12 '25
“Taylor Morrison 8 % - %”
None